Smith & Nephew Insider Transaction

2 min read | December 06, 2024 10:44 PM AEDT | By Team Kalkine Media

Google News:

Smith & Nephew Insider Transaction — Image source: Shutterstock

Recent News

Iron Ore Giants Adjust as Simandou Reshapes Market

ASX Mining Dividends: Fortescue vs Rio Tinto vs BHP

Lithium Stocks Ignite as ASX Battery Boom Returns

Can ASX 300 Lithium Stocks Sustain Gains as Spodumene Prices Tighten?

Make Kalkine Media
My Trusted Source

Highlights

Smith & Nephew (LON:SN) insider Deepak Nath sold 34,033 shares on December 5th.

The company’s stock opened at GBX 978.80 on Friday, with a market cap of £8.53 billion.

Smith & Nephew continues to show solid performance with a PE ratio of 3,645.93 and a 200-day moving average of GBX 1,075.48.

Smith & Nephew plc (LON:SN), a global leader in medical devices, reported insider activity on Thursday, December 5th. Deepak Nath, an insider, sold 34,033 shares at an average price of GBX 981. The total transaction amounted to £333,863.73, reflecting the company's market dynamics. As a part of the LON healthcare stocks sector, Smith & Nephew continues to play a significant role in the global healthcare and medical device industry.

This insider sale occurred amidst fluctuating stock performance. Smith & Nephew's stock opened at GBX 978.80 on Friday, slightly below its previous levels. The company maintains a solid financial structure, with a current ratio of 2.51 and a quick ratio of 0.84. Despite the sale, the stock is supported by key indicators, such as a 50-day moving average of GBX 1,042.88 and a 200-day moving average of GBX 1,075.48.

With a market capitalization of £8.53 billion, Smith & Nephew holds a strong position in the healthcare sector, particularly within orthopaedics, sports medicine, and advanced wound management. The company continues to innovate, offering a range of medical devices from knee and hip implants to trauma stabilization products.

Despite the insider transaction, Smith & Nephew remains a prominent player in the medical device industry, with a price-to-earnings ratio (PE) of 3,645.93 and a relatively low beta of 0.62. These metrics highlight the company's potential for stability in the ever-evolving healthcare sector.

Smith & Nephew's position in the market continues to solidify as it moves forward with its product offerings, catering to both local and international markets. The company remains a key entity within its industry, focusing on orthopaedic solutions, sports medicine, and advanced wound care.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.